BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou HQ, Liu MS, Deng TB, Xie PB, Wang W, Shao T, Wu Y, Zhang P. The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells. Onco Targets Ther 2019;12:7809-21. [PMID: 31576139 DOI: 10.2147/OTT.S212596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yadav P, Kundu P, Pandey VK, Amin PJ, Nair J, Shankar BS. Effects of prolonged treatment of TGF-βR inhibitor SB431542 on radiation-induced signaling in breast cancer cells. Int J Radiat Biol 2022;:1-18. [PMID: 35446183 DOI: 10.1080/09553002.2022.2069299] [Reference Citation Analysis]
2 Liu YY, Ding CZ, Chen JL, Wang ZS, Yang B, Wu XM. A Novel Small Molecular Inhibitor of DNMT1 Enhances the Antitumor Effect of Radiofrequency Ablation in Lung Squamous Cell Carcinoma Cells. Front Pharmacol 2022;13:863339. [PMID: 35401185 DOI: 10.3389/fphar.2022.863339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Zou XZ, Hao JF, Zhou XH. Inhibition of SREBP-1 Activation by a Novel Small-Molecule Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Tissue to Radiofrequency Ablation. Front Oncol 2021;11:796152. [PMID: 34900747 DOI: 10.3389/fonc.2021.796152] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
4 Mardomi A, Ghollasi M, Korani M, Panahi M, Parsa-Kondelaji M, Sabzichi M, Salimi A. Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model. Naunyn Schmiedebergs Arch Pharmacol 2021;394:2309-22. [PMID: 34499199 DOI: 10.1007/s00210-021-02134-x] [Reference Citation Analysis]
5 Huang Y, Liao L, Su H, Chen X, Jiang T, Liu J, Hou Q. Psoralen accelerates osteogenic differentiation of human bone marrow mesenchymal stem cells by activating the TGF-β/Smad3 pathway. Exp Ther Med 2021;22:940. [PMID: 34306204 DOI: 10.3892/etm.2021.10372] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Lv SW, Shi ZG, Wang XH, Zheng PY, Li HB, Han QJ, Li ZJ. Ribosome Binding Protein 1 Correlates with Prognosis and Cell Proliferation in Bladder Cancer. Onco Targets Ther 2020;13:6699-707. [PMID: 32764960 DOI: 10.2147/OTT.S252043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]